arteries and 19 superior mesenteric arteries) targeted with 44 fenestrations and 17 scallops; 44 target vessels were stented with 41 covered stents and 3 bare-metal stents. Median follow-up was 255 days (range, 34-1352 days). Of the 22 completion endoleaks, 12 were type III, one was type IA, and 9 were indeterminate (either type IA or type III; Table) . No type I or type III endoleaks were identified on initial postoperative computed tomography angiography. Furthermore, no type I or type III endoleaks were identified on any follow-up imaging. Of 12 patients with at least 6-month follow-up, 6 had sac regression, 5 had stable sac diameter, and 1 had sac expansion. The patient with sac expansion underwent reintervention for persistent type II endoleak. There were no aneurysm ruptures or deaths.
IP071.

Comparison of Fenestrated Endovascular and
Objective: The aim of this monocentric retrospective study was to compare outcomes of fenestrated endovascular aneurysm repair (FEVAR) and open surgical repair (OR) of suprarenal abdominal aortic aneurysms and type IV thoracoabdominal aneurysms (TAAAs).
Methods: Consecutive patients undergoing elective FEVAR and OR of suprarenal and type IV TAAAs between January 2012 and November 2015 were included. Choice between FEVAR and OR was based on anatomic criteria and the patient's comorbidities. In the OR group, an extracorporeal circulation was systematically used to provide oxygenated isothermic blood to the renal and the visceral arteries during aortic clamping.
Results: During the study period, 26 patients underwent FEVAR and 26 underwent OR. Patients in the FEVAR group were significantly older (FEVAR, 74 6 8 years; OR, 67 6 8 years; P < .001) and had a lower preoperative glomerular filtration rate (FEVAR, (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) (81) Moderate to severe complication rates were 54% (14/26) in the FEVAR group and 65% (17/26; P ¼ .4) in the OR group. Permanent paraplegia occurred in one (4%) FEVAR patient and two (8%) OR patients. In the FEVAR group, two (8%) patients required permanent dialysis. In the OR group, four (15%) patients required transient dialysis. The mean followup time was 37 6 20 months after FEVAR and 35 6 18 months after OR. At 24 months, the actuarial survival rate was significantly higher in the OR group (FEVAR group, 62%; OR group, 92%; log-rank test, P ¼ .03), and estimated freedom from reintervention rates (FEVAR vs OR group, 64% vs 64%; log-rank test, P ¼ .63) were not significantly different between both groups.
Conclusions: In this study, no significant difference in terms of postoperative mortality, complication, and reintervention rates could be identified between FEVAR and OR for suprarenal and type IV TAAAs. OR provided good midterm results.
Author Disclosures: E. Allaire: Nothing to disclose; I. Ben Abdallah: Nothing to disclose; F. Cochennec: Nothing to disclose; P. Desgranges: Nothing to disclose; J. Sénémaud: Nothing to disclose; J. Touma: Nothing to disclose. Objective: Readmissions after acute type A aortic dissection (AAAD) are not well described. Characterization of causes and identification of predictors of readmission could result in improved outcomes. We evaluated our experience to determine the rate and to identify risk factors for readmission after open AAAD repair managed at our institution during a decade.
IP073. Predictors and Descriptors of Readmissions After Acute Aortic Dissection
Methods: Of the 435 patients who presented to our service between 2004 and 2014, there were 411 who underwent repair for AAAD. Of these, 357 survived the initial hospitalization and were evaluated for this analysis. Follow-up was performed through prospective phone contact and retrospective review of records under an Institutional Review Boardapproved protocol to obtain the cause, frequency, length of stay, management, and related characteristics for each reported readmission and emergency department visit. Data were analyzed by univariate and multivariable analysis.
Results: Of those who survived AAAD repair, 64 (16%) had readmissions within 30 days. The median interval between initial discharge and readmission was 7 (interquartile range, 3-21) days. The 30-day readmission rate was slightly more in women (23% vs 16%), younger patients (53 vs 57 years), and substance abusers (17% vs 7%; P < .008). The median readmission length of stay was 3 days (interquartile range, 1-12 days). Multivariable analysis identified age <60 years, female sex, coronary artery disease, substance abuse, and postoperative infection to be predictive of 30-day readmissions. During a median follow-up of 5 years, 204 (57%) patients were readmitted for various aortic (17%), cardiac (15%), neurologic (10%), hypertensive crisis (10%), and gastrointestinal (15%) reasons. Recurrent or persistent pain (21%) was one of the most significant predictors for multiple readmissions (P < .001) in addition to connective tissue disorder (odds ratio, 3.2; P < .016). Overall, 12% of patients required aortic reinterventions during a median of 2 years after initial AAAD repair. Of these, proximal aortic repair (redo or root) was performed in 22% of cases and distal thoracoabdominal aortic repair in 88% (36). Independent correlates of aortic event readmissions included age >70 years, connective tissue disorder, female sex, postoperative bleeding complications, low baseline glomerular filtration rate, and multiple readmissions. Long-term readmission-free and aortic event-free survival at 1 year and 5 years were 40% and 56% and 87% and 76%, respectively.
Conclusions: Readmission after repair of AAAD is common. Age <60 years, female sex, coronary artery disease, substance abuse, and postoperative infection were strong predictors of early readmissions. Recurrent (chest, back, abdominal) pain was significantly correlated with multiple readmissions and low event-free survival. Routine surveillance after repair of AAAD is recommended with closer attention to patients with recurrent or persistent pain.
Author Disclosures: K. M. Charlton-Ouw: Nothing to disclose; A. L. Estrera: Nothing to disclose; I. Jamshidy: Nothing to disclose; C. C. Miller: Nothing to disclose; A. Ray: Nothing to disclose; H. J. Safi: Nothing to disclose; H. K. Sandhu: Nothing to disclose; A. Tanaka: Nothing to disclose.
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